Hanimune Therapeutics raises $3.3M, sets sights on first food allergy treatment product

The company is working on a therapy to help people who suffer from egg allergies.

Hanimune Therapeutics raises $3.3M, sets sights on first food allergy treatment product
The company is working on a therapy to help people who suffer from egg allergies.